RSS

Cancer Drugs Fund (CDF)

NHS England has revealed that thousands of patients have benefited from the new CDF and as a result of discounts it has secured on eight treatments, savings of around £140 million should be generated over the course of the next five years more

News

Opdivo, also known as nivolumab, will now be available to NHS patients suffering from lung cancer as the drug’s manufacturer, Bristol-Myers Squibb, offers the National Institute for Health and Care Excellence (NICE) a new cancer drugs fund (CDF) deal more

News

An analysis by King’s College London has found that the NHS Cancer Drugs Fund (CDF) was not good value for patients and society, and may have resulted in patients suffering from toxic side effects of the drugs. more

News

A drug used to treat breast cancer has been rejected for use on the NHS due to its high cost. more

News

A drug that can lead to the reduction in lung cancer tumours has been made available on the NHS. more

News

Following a closed-door period, the UK's Cancer Drugs Fund is once again accepting new treatments. more

News

In light of NHS England's plan to remove 25 uses of cancer medicines from the Cancer Drugs Fund (CDF) on 12 March, a new survey has revealed considerable dissatisfaction amongst oncologists with some of the proposed changes. more

News

Sanofi has spoken out about recent cuts to the UK's Cancer Drugs Fund, which will see at least two of its drugs delisted from March 12th. more

News

Thousands more cancer patients in England will be offered vital treatments in a £160 million boost to the Cancer Drugs Fund. more

Jamie Mallinson, GlobalData’s analyst covering oncology and hematology, describes the NICE rejection as "no big surprise". more